MXiPr

MXiPr (Methoxisopropamine): Research Chemical Profile and Legal Status

MXiPr, short for Methoxisopropamine, is a novel dissociative compound belonging to the arylcyclohexylamine family. Structurally related to MXE, MXPr, and ketamine, MXiPr contains a unique isopropylamino group, setting it apart for advanced neuropharmacological and receptor-binding studies.

It is used by scientific researchers in NMDA receptor studies, structure-activity relationship (SAR) comparisons, and analytical chemistry development. MXiPr is not intended for human or animal consumption, and is supplied exclusively for laboratory use.

Chemical Overview and Structure

MXiPr features a methoxy substitution on the aromatic ring and an isopropylamine chain at the amine position. This structure influences its binding affinity and receptor selectivity, making it valuable in comparative research with ketamine analogs.

  • IUPAC Name: 2-(isopropylamino)-2-(o-methoxyphenyl)cyclohexanone

  • Molecular Formula: C16H25NO2

  • Chemical Class: Arylcyclohexylamine, dissociative anesthetic analog

  • Physical Form: White or off-white crystalline powder

  • Applications: NMDA receptor analysis, SAR exploration, forensic reference

This compound is closely monitored in academic research due to its novel substitution pattern and emerging relevance in receptor-binding assays.

Anecdotal Reports (Unverified Observations)

Although MXiPr has not been approved for clinical use or toxicological testing, anecdotal data from researchers suggests its dissociative effects are comparable to other compounds in its class, with unique properties influenced by the isopropyl group.

Unverified effects may include:

  • Dissociative mental states

  • Altered perception of time, space, and identity

  • Emotional detachment or introspection

  • Potentially longer duration than ketamine

  • Variable potency compared to MXE or MXPr

These reports are included for reference only and do not represent confirmed scientific data.

Laboratory Handling and Safety Precautions

Because of its novel chemical nature, MXiPr must be handled with full laboratory safety procedures. This includes use only in secure, professionally equipped environments by qualified researchers.

Handling recommendations include:

  • Use of gloves, goggles, and protective garments

  • Work in a fume hood or ventilated environment

  • Accurate measurement using microgram-scale instruments

  • Storage in a cool, dry, clearly labeled container

  • Waste disposal according to chemical safety guidelines

Proper handling minimizes risk and ensures research integrity.

Legal Status of MXiPr

MXiPr is currently a grey-area substance in many countries. While not explicitly scheduled under most controlled substance acts, it may be restricted under analogue legislation or blanket psychoactive substance laws.

  • United States: Unscheduled; potentially covered by the Federal Analog Act

  • United Kingdom: May be restricted under the Psychoactive Substances Act (PSA)

  • Germany: Likely covered by the NpSG (New Psychoactive Substances Act)

  • Canada & Australia: Possibly subject to analog control provisions

  • European Union: Legal status varies by country

It is the researcher’s responsibility to verify all local regulations before purchasing or handling MXiPr.

For Research Use Only

MXiPr is not for human or veterinary consumption. This compound is intended exclusively for use in forensic, analytical, and scientific research by certified professionals in legally compliant environments.

Shopping Cart